The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
Introduction: A New Era in Precision Oncology For decades, the prevailing philosophy in oncology was "more is...
